Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
Blood Advances|December 3, 2024
Inaticabtagene autoleucel in adult relapsed or refractory B-cell acute lymphoblastic leukemiaYing Wang, Lulu Lv, Yongping Song, et al.
Cancer Communications (London, England)|February 26, 2024
Targeting autophagy overcomes cancer-intrinsic resistance to CAR-T immunotherapy in B-cell malignanciesLu Tang, Huan Zhang, Fen Zhou, et al.
Journal of Hematology & Oncology|October 10, 2021
A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myelomaHeng Mei, Chenggong Li, Huiwen Jiang, et al.
American Journal of Hematology|April 6, 2026
Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 TrialNichola Cooper, Catherine M Broome, Yoshitaka Miyakawa, et al.
Blood Advances|August 14, 2025
Phase 2 Study of Relmacabtagene Autoleucel (CD19 CAR-T) for Relapsed/Refractory Mantle Cell Lymphoma in Chinese AdultsYan Xie, Keshu Zhou, Lanfang Li, et al.
Leukemia|May 19, 2021
JunB is a key regulator of multiple myeloma bone marrow angiogenesisFengjuan Fan, Stefano Malvestiti, Sonia Vallet, et al.
Scientific Reports|August 24, 2017
Evaluation of the new Chinese Disseminated Intravascular Coagulation Scoring System in critically ill patients: A multicenter prospective studyYingying Wu, Lili Luo, Ting Niu, et al.
Thrombosis Research|December 12, 2018
A multicenter, prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulationLili Luo, Yingying Wu, Ting Niu, et al.
The Lancet. Haematology|April 7, 2023
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 studyXiaofan Liu, Hu Zhou, Yu Hu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 22, 2023
Sequence Variation of Candida albicans Sap2 Enhances Fungal Pathogenicity via Complement Evasion and Macrophage M2-Like Phenotype InductionLan Lin, Moran Wang, Jingsi Zeng, et al.
Pageof 19